Company: CPMV
Filing Date: 2025-08-19
Form Type: 10-Q
Source: 0001683168-25-006318
Chunk: 44

Company: Mosaic ImmunoEngineering Inc.
Filing Date: 2025-08-19
Form: 10-Q
Item: Part I, Item 4
Chunk 44
---
 herewith. 

 22 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this Report to be signed on its behalf by the undersigned thereunto duly authorized.

    Dated: August 19, 2025
    
    MOSAIC IMMUNOENGINEERING, INC.
     
    /s/ Steven King                                     
    
    Steven King. President, Chief Executive Officer, Director
    (Principal Executive Officer, Principal Financial Officer and
    Principal
    Accounting Officer)

 23